A Long Term Open Label Rollover Trial Assessing the Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV-1 Infected Subjects.
Phase of Trial: Phase II/III
Latest Information Update: 02 May 2014
At a glance
- Drugs Tipranavir (Primary) ; Ritonavir
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 07 Aug 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
- 17 Nov 2005 New trial record.